Concepedia

Author

Frank Vari

The University of QueenslandORCID

Also Known As

, F VARI, F Vari, F. Vari, Frank Vari, VARI

97

Publications

1.9K

Citations

22

H-Index

40

Concepts

All Affiliations

The University of QueenslandQIMR Berghofer Medical Research InstitutePrincess Alexandra HospitalMater ResearchTranslational Research Institute
FV

About

Frank Vari is an author at The University of Queensland specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

499

2

Cell Biology

6

6

276

3

Hepatology

2

2

51

4

Health Sciences

1

1

14

5

Allergy

1

1

37

Frank Vari

×

30

Publications

1.8K

Citations

22

H-Index

YearCitations

Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL

Frank Vari, David Arpon, Colm Keane,

Blood

2018

304

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan,

Immunity

2020

169

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

Joshua W.D. Tobin, Colm Keane, Jay Gunawardana,

Journal of Clinical Oncology

2019

157

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

Maher K. Gandhi, Thanh Hoang, Soi Cheng Law,

Blood

2020

112

Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma

Kimberley Jones, Frank Vari, Colm Keane,

Clinical Cancer Research

2012

107

A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer

Rebecca L. Prue, Frank Vari, Kristen J. Radford,

Journal of Immunotherapy

2015

102

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study

Colm Keane, Frank Vari, Mark Hertzberg,

The Lancet Haematology

2015

93

CD4<sup>+</sup> Tumor infiltrating lymphocytes are prognostic and independent of R‐IPI in patients with DLBCL receiving R‐CHOP chemo‐immunotherapy

Colm Keane, Devinder Gill, Frank Vari,

American Journal of Hematology

2013

91

The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma

Colm Keane, Clare Gould, Kimberley Jones,

Clinical Cancer Research

2016

84

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West,

Blood

2019

61

Page 1